Disposition of 47392 shares by Adam Tomasi of Allakos at 1.44 subject to Rule 16b-3

ALLK Stock  USD 0.89  0.02  2.30%   
About 55% of Allakos' institutional investors are presently thinking to get in. The analysis of the overall investor sentiment regarding Allakos suggests that some traders are interested. Allakos' investing sentiment shows overall attitude of investors towards Allakos.
  
Filed transaction by Allakos Officer: President. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Read at macroaxis.com
Disposition of 47392 common stock at 1.44 of Allakos by Adam Tomasi on 5th of March 2024. This event was filed by Allakos with SEC on 2024-03-05. Statement of changes in beneficial ownership - SEC Form 4

Cash Flow Correlation

Allakos' cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Allakos' relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.
Click cells to compare fundamentals

Allakos Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Allakos can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Allakos Fundamental Analysis

We analyze Allakos' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Allakos using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Allakos based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Current Ratio

Current Ratio Comparative Analysis

Allakos is currently under evaluation in current ratio category among its peers. Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.

Allakos Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Allakos stock to make a market-neutral strategy. Peer analysis of Allakos could also be used in its relative valuation, which is a method of valuing Allakos by comparing valuation metrics with similar companies.

Peers

Allakos Related Equities

FATEFate Therapeutics   10.74   
0%
100.0%
ALLOAllogene Therapeutics   10.53   
0%
98.0%
RCUSArcus Biosciences   8.45   
0%
78.0%
ASMBAssembly Biosciences   7.24   
0%
67.0%
CTMXCytomX Therapeutics   6.25   
0%
58.0%
ANNXAnnexon   3.73   
0%
34.0%
SGMOSangamo Therapeutics   2.80   
0%
26.0%
APLSApellis Pharmaceuticals   2.26   
0%
21.0%
CRBUCaribou Biosciences   2.02   
0%
18.0%
CRNXCrinetics Pharmaceuticals   1.21   
0%
11.0%
ATRAAtara Biotherapeutics   1.16   
0%
10.0%
DAWNDay One   0.89   
0%
8.0%
BPMCBlueprint Medicines   0.81   
0%
7.0%
RAREUltragenyx   0.51   
0%
4.0%
RVMDRevolution Medicines   0.03   
1.0%
0%
SANASana Biotechnology   1.21   
11.0%
0%
SPROSpero Therapeutics   1.74   
16.0%
0%
KURAKura Oncology   1.92   
17.0%
0%
NXTCNextCure   2.50   
23.0%
0%
ARVNArvinas   2.66   
24.0%
0%
HRTXHeron Therapeuti   3.51   
32.0%
0%
When determining whether Allakos is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Allakos Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Allakos Stock. Highlighted below are key reports to facilitate an investment decision about Allakos Stock:
Check out Allakos Hype Analysis, Allakos Correlation and Allakos Performance.
For more information on how to buy Allakos Stock please use our How to buy in Allakos Stock guide.
You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Allakos. If investors know Allakos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Allakos listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.03)
Return On Assets
(0.49)
Return On Equity
(1.22)
The market value of Allakos is measured differently than its book value, which is the value of Allakos that is recorded on the company's balance sheet. Investors also form their own opinion of Allakos' value that differs from its market value or its book value, called intrinsic value, which is Allakos' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Allakos' market value can be influenced by many factors that don't directly affect Allakos' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Allakos' value and its price as these two are different measures arrived at by different means. Investors typically determine if Allakos is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Allakos' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.